Generic pharmaceutical pricing
1 story tracked · latest
144
Case tracking for the Generic pharmaceutical pricing matter, current through August 11, 2026, plus any additional news coverage found automatically below. Allegations may be disputed; a listing does not establish liability or individual eligibility.
Recent coverage
ANTITRUST—E.D. Pa.: Generic drug pricing MDL claims advance as court sustains overarching conspiracy allegations - VitalLaw.com
A federal multidistrict antitrust case over alleged coordinated generic-drug pricing has advanced after the court allowed broad conspiracy claims to proceed.
Curated matter facts are cited to public reporting and official sources and are not GPT-generated. Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.